Categories: Market Research

Pediatric Neurology Device Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Pediatric Neurology Device Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Pediatric Neurology Device Market:

https://www.thebusinessresearchcompany.com/report/pediatric-neurology-device-global-market-report

According to The Business Research Company’s Pediatric Neurology Device Global Market Report 2024, The pediatric neurology device market size has grown strongly in recent years. It will grow from $2.33 billion in 2023 to $2.5 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increased awareness and early diagnosis, government support for pediatric healthcare, collaborations in pediatric neurological research, improvements in pediatric healthcare infrastructure, growing prevalence of pediatric neurological disorders, patient advocacy and support groups..

The pediatric neurology device market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to global emphasis on child health, integration of personalized medicine, rising awareness of early intervention, global health policies for children, international collaboration in pediatric healthcare.. Major trends in the forecast period include advancements in wearable neurological monitoring devices, integration of artificial intelligence in diagnostic tools, development of pediatric-specific neuromodulation devices, expansion of telehealth and remote monitoring solutions, introduction of child-friendly neuroimaging technologies, focus on non-invasive and minimally invasive interventional techniques..

The rising prevalence of autism in children is expected to boost the growth of the pediatric neurology devices market going forward. Autism is a developmental condition that interferes with how a person perceives and interacts with others, making it difficult for them to communicate and interact with others. Pediatric neurology devices are designed to help children with autism to be diagnosed and treated, and they also aid with their quality of life, social skills, and cognitive and behavioral symptoms. For instance, in March 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based government organization, data from 11 communities in the Autism and Developmental Disabilities Monitoring (ADDM) Network in the US, showed that one in 36 (2.8%) 8-year-old children have been identified with autism spectrum disorder (ASD). Therefore, the rising prevalence of autism in children is driving the growth of the pediatric neurology devices market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=13506&type=smp

The pediatric neurology device market covered in this report is segmented –

1) By Product Type: Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices, Other Types

2) By Condition: Stroke, Seizures, Hydrocephalus, Oncology, Other Conditions

3) By Service And Treatment: Electroencephalogram, Intrathecal Baclofen Therapy, Neurological Evaluations, Vagal Nerve Stimulation, Other Services And Treatments

4) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

Major companies operating in the pediatric neurology device market are developing new products, such as external trigeminal nerve stimulation devices, to meet larger customer bases, increase sales, and increase revenue. An external trigeminal nerve stimulation device is a minimally invasive medical treatment that uses a small electrical device applied to the forehead to administer neuromodulation. For instance, in October 2022, NeuroSigma Inc., a US-based medical device company, launched Monarch external Trigeminal Nerve Stimulation (eTNS) System to treat patients with attention-deficit/hyperactivity disorder (ADHD) aged 7 to 12 who are not receiving medication for the condition. This device’s unique feature is that, while a patient sleeps, a small patch is applied to their forehead, delivering a low-level electrical pulse to the trigeminal nerve. Based on the clinician-administered ADHD Rating Scale (ADHD-RS) score, clinical trial results demonstrated that treatment with the eTNS device improved ADHD symptoms statistically significantly more than placebo.

The pediatric neurology device market report table of contents includes: